Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
UNC Lineberger Comprehensive Cancer Center
Inhibrx Biosciences, Inc
Constellation Pharmaceuticals
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Hoffmann-La Roche
Novartis
Celgene
BeiGene
Takara Bio Inc.
Atara Biotherapeutics
Shenzhen University General Hospital
Astex Pharmaceuticals, Inc.
Theseus Pharmaceuticals
AO GENERIUM
Genelux Corporation
Takeda
Beijing Immunochina Medical Science & Technology Co., Ltd.
Amgen Research (Munich) GmbH
AVEO Pharmaceuticals, Inc.
Jichi Medical University
Centocor, Inc.